Production (Stage)
REGENXBIO Inc.
RGNX
$10.08
-$0.05-0.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 267.87M | 234.69M | 255.46M | 290.36M | 338.70M |
| Total Receivables | 33.24M | 32.87M | 45.48M | 45.12M | 41.85M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 11.09M | 9.07M | 11.00M | 10.02M | 13.59M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.04M | 1.38M | 1.45M | 1.19M | 1.27M |
| Total Current Assets | 313.24M | 278.00M | 313.40M | 346.68M | 395.42M |
|
|
|||||
| Total Current Assets | 313.24M | 278.00M | 313.40M | 346.68M | 395.42M |
| Net Property, Plant & Equipment | 166.61M | 171.31M | 175.84M | 180.31M | 185.22M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.23M | 6.50M | 6.77M | 5.44M | 6.77M |
| Total Assets | 490.93M | 465.99M | 519.11M | 569.38M | 629.22M |
|
|
|||||
| Total Accounts Payable | 19.04M | 22.80M | 19.52M | 16.36M | 31.36M |
| Total Accrued Expenses | 23.56M | 37.91M | 48.31M | 42.35M | 32.98M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 50.50M | 42.21M | 34.42M | 39.40M | 45.68M |
| Total Finance Division Other Current Liabilities | 13.62M | 271.00K | 478.00K | 158.00K | 162.00K |
| Total Other Current Liabilities | 13.62M | 271.00K | 478.00K | 158.00K | 162.00K |
| Total Current Liabilities | 106.73M | 103.19M | 102.73M | 98.27M | 110.18M |
|
|
|||||
| Total Current Liabilities | 106.73M | 103.19M | 102.73M | 98.27M | 110.18M |
| Long-Term Debt | 11.12M | 25.38M | 35.05M | 41.08M | 44.70M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 71.91M | 74.13M | 76.34M | 78.23M | 80.18M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 26.98M | 3.64M | 3.58M | 3.53M | 3.49M |
| Total Liabilities | 216.73M | 206.34M | 217.70M | 221.11M | 238.55M |
|
|
|||||
| Common Stock & APIC | 1.20B | 1.19B | 1.18B | 1.17B | 1.16B |
| Retained Earnings | -926.07M | -932.15M | -880.96M | -821.37M | -768.38M |
| Treasury Stock & Other | -762.00K | -741.00K | -582.00K | -2.27M | -3.23M |
| Total Common Equity | 274.20M | 259.65M | 301.42M | 348.27M | 390.67M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 274.20M | 259.65M | 301.42M | 348.27M | 390.67M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 274.20M | 259.65M | 301.42M | 348.27M | 390.67M |
|
|
|||||